To investigate this, NSCLC cells (H460) were treated with volasertib, ERK1/2 small molecule inhibitor SCH772984, or both drugs, and PD-L1 expression was assessed by flow cytometry. The gene discussed is CD274; the disease is non-small cell lung carcinoma.